SGLT-2 Inhibitor- Dapagliflozin Induced Dizziness -A Case Report

Authors

  • Dr. Vinodhini S Junior Resident, Department of Pharmacology, Coimbatore Medical College, Coimbatore.
  • Dr. Madhan L Professor & Head of the Department, Department of Pharmacology, Coimbatore Medical College, Coimbatore.
  • Dr. Nithya Priya M Assistant Professor, Department of Pharmacology, Coimbatore Medical College, Coimbatore.

Keywords:

Diabetes Mellitus, SGLT-2 inhibitors, Dapagliflozin, Dizziness, Hypotension

Abstract

Herein the author presents a case report of a 45 years old obese male with type II diabetes mellitus started on Dapagliflozin, presented with complaints of polyuria and dizziness after a week. In this case report the author discusses the SGLT-2 inhibitor induced dizziness and its treatment.

References

Balkanski S. Dapagliflozin – structure, synthesis, and new indications. Pharmacia. 2021;68(3): 591-596. https://doi.org/10.3897/pharmacia.68.e70626

Cho HA, Jung YL, Lee YH, Lee YC, Lee JE, Lee SJ, Jeong SJ, Kim CH. Efficacy of Body Weight Reduction on the SGLT2 Inhibitor in People with Type 2 Diabetes Mellitus. J Obes Metab Syndr. 2017;26(2):107-113. doi:10.7570/jomes.2017.26.2.107. Epub 2017 Jun 30. PMID: 31089504; PMCID: PMC6484898.

Filippatos TD, Tsimihodimos V, Elisaf MS. Mechanisms of blood pressure reduction with sodium-glucose co-transporter 2 (SGLT2) inhibitors. Expert Opin Pharmacother. 2016;17(12):1581-3. doi:10.1080/14656566.2016.1201073. Epub 2016 Jun 24. PMID: 27295549.

Downloads

Published

2022-12-30

How to Cite

S, V., L, M., & M, N. P. (2022). SGLT-2 Inhibitor- Dapagliflozin Induced Dizziness -A Case Report. The Journal of Medicine and Science, 1(03), 15–16. Retrieved from https://tjms.in/index.php/tjms/article/view/19

Issue

Vol. 1 No. 03 (2022): December 2022

Section

Case reports

License

Copyright (c) 2022 Dr. S Vinodhini, Dr. Madhan L, Dr. M Nithya Priya

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

CC BY License